SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001504167-19-000015
Filing Date
2019-05-22
Accepted
2019-05-22 16:22:32
Documents
5
Period of Report
2019-07-10
Effectiveness Date
2019-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A bpmx-20190710xdef14a.htm DEF 14A 498048
2 GRAPHIC bpmx20190710xdef14a001.jpg GRAPHIC 4958
3 GRAPHIC bpmx20190710xdef14a002.jpg GRAPHIC 9845
4 GRAPHIC bpmx20190710xdef14a003.gif GRAPHIC 147549
5 GRAPHIC bpmx20190710xdef14a004.gif GRAPHIC 48272
  Complete submission text file 0001504167-19-000015.txt   789353
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-37411 | Film No.: 19846042
SIC: 2834 Pharmaceutical Preparations